Nurulimab Antibody
Nurulimab (BCD-145) is a human monoclonal antibody targeting CTLA-4, developed for anticancer research. It is utilized in preclinical studies for skin and musculoskeletal diseases, supporting both in vitro assays and in vivo model experiments to investigate immune checkpoint blockade mechanisms.
Product Specifications
Product Name Alternative
CTLA-4, BCD145, BCD-145
Target
Immunology/Inflammation related, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.65 mg/mL
Purity
95.50% (May vary between batches)
Molecular Weight
145.01 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
212548-01 20 µL
PDZK1 (PDZ Domain-containing Protein 1, CFTR-associated Protein of 70kD, CAP70, CLAMP, PDZD1, NHERF3, NHERF-3) discontinued
Sign In for Pricing
View Details 212548-02 100 µL
PDZK1 (PDZ Domain-containing Protein 1, CFTR-associated Protein of 70kD, CAP70, CLAMP, PDZD1, NHERF3, NHERF-3) discontinued
Sign In for Pricing
View Details E4740m 96 Tests
ELISA Kit For Diphosphoinositol polyphosphate phosphohydrolase 3-beta
Sign In for Pricing
View Details